Treatment Set TS329526

Product NDC

49288-0737

11-digit product format

492880737

Labeler code

49288

Product ID

49288-0737_b29faef0-2249-45b7-974b-212faa8c91d8

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Treatment Set TS329526

Dosage form

INJECTION, SOLUTION

Route

INTRADERMAL; SUBCUTANEOUS

Labeler

Antigen Laboratories, Inc.

Application

BLA102223

Marketing category

BLA

Marketing start

1986-10-31

Marketing end

0000-00-00

Substance

ALTERNARIA ALTERNATA; AMBROSIA ARTEMISIIFOLIA POLLEN; QUERCUS ALBA POLLEN; PHLEUM PRATENSE POLLEN; DERMATOPHAGOIDES FARINAE

Active strength

0 g/mL; [AU]/mL; g/mL; [BAU]/mL; [AU]/mL

Pharmacologic classes

Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Allergens [CS],Insect Proteins [CS],Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [CS]

NDC exclude flag

E

Listing certified through

2017-12-31

Current FDA listing

Historical FDA.report record